In The News
CMA issues statement of objections to Fender for resale price
maintenance
The CMA has issued a statement of objections to Fender,
provisionally finding that the guitar company restricted online
discounting by its retailers. Click here.
CMA issues statement of objections and accepts commitments in
Aspen fludrocortisone case
The CMA has issued a statement of objections and accepted
commitments in the Aspen fludrocortisone case. The statement of
objections sets out the CMA's provisional view that, in 2016,
Aspen agreed to pay two other firms, Amilco and Tiofarma, to stay
out of the UK market for fludrocortisone acetate tablets. The
commitments relate to Aspen's 2016 purchase of a competitor
fludrocortisone product from Tiofarma authorised for supply in the
UK. This acquisition brought all existing fludrocortisone marketing
authorisations in the UK permanently under Aspen's ownership.
The commitments include Aspen offering to pay the NHS £8
million,
